Clinical Trial Update: JSKN016 in Combination With D-0502 for Locally Advanced or Metastatic HR-Positive, HER2-Negative Breast Cancer [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial update for JSKN016 in combination with D-0502 in HR-positive, HER2-negative metastatic or locally advanced breast cancer, currently n…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• D-0502
• JSKN016

Snippet

Sponsor: Jiangsu Alphamab Biopharmaceuticals Co., Ltd | Conditions: Metastatic Breast Cancer, Locally Advanced Breast Cancer (LABC) | Phase 1, Phase 2 | Status: NOT_YET_RECRUITING